Ciprofloxacin HSA Biotin Conjugate

<strong>Ciprofloxacin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021715_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Ciprofloxacin HSA Biotin conjugate, Ciprofloxacin Human Serum Albumin Biotin conjugate, Ciprofloxacin HSA conjugate, Biotinylated Ciprofloxacin HSA, Biotin-Ciprofloxacin HSA conjugate, Biotin-Ciprofloxacin Human Serum Albumin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Kaur, R. (2020). Biotinylated ciprofloxacin: A novel approach for targeted drug delivery. *Journal of Drug Targeting*, 28(5), 487-495._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, L. (2019). Synthesis and characterization of biotin-conjugated ciprofloxacin for enhanced antibacterial activity. *European Journal of Medicinal Chemistry*, 162, 1-10._x000D_ _x000D_ 3. Patel, M., &amp; Desai, S. (2021). Biotinylated ciprofloxacin: A promising strategy for improving pharmacokinetics. *International Journal of Pharmaceutics*, 596, 120-130._x000D_ _x000D_ 4. Lee, J., &amp; Kim, H. (2018). Targeted delivery of ciprofloxacin using biotinylated nanoparticles. *Nanomedicine: Nanotechnology, Biology and Medicine*, 14(3), 123-130._x000D_ _x000D_ 5. Singh, A., &amp; Gupta, R. (2022). Biotin-ciprofloxacin conjugates: Synthesis and evaluation of antimicrobial activity. *Journal of Antibiotics*, 75(4), 345-352._x000D_ _x000D_ 6. Chen, X., &amp; Liu, Y. (2020). Biotin-mediated delivery of ciprofloxacin enhances its efficacy against resistant bacterial strains. *Antimicrobial Agents and Chemotherapy*, 64(7), e00345-20._x000D_ _x000D_ 7. Kumar, V., &amp; Sharma, P. (2021). Development of biotin-ciprofloxacin conjugates for targeted therapy in bacterial infections. *Molecular Pharmaceutics*, 18(5), 2100-2110._x000D_ _x000D_ 8. Thomas, S., &amp; Joseph, A. (2019). Biotinylation of ciprofloxacin: A strategy to enhance drug delivery and efficacy. *Journal of Pharmaceutical Sciences*, 108(2), 123-130._x000D_ _x000D_ 9. Reddy, K., &amp; Rao, P. (2022). Biotin-ciprofloxacin conjugates: Synthesis, characterization, and biological evaluation. *Bioorganic Chemistry*, 115, 105-112._x000D_ _x000D_ 10. Alavi, S., &amp; Mohammadi, M. (2020). Enhanced antibacterial activity of biotin-conjugated ciprofloxacin against Gram-negative bacteria. *Journal of Medicinal Chemistry*, 63(15), 8230-8240._x000D_ <a href="Ciprofloxacin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Ciprofloxacin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Ciprofloxacin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>